Salicin, an extract from white willow bark, inhibits angiogenesis by blocking the ROS-ERK pathways

Kong, C.S., Kim, K.H., Choi, J.S., Kim, J.E. and others · Phytotherapy Research · 2014

Preclinical

Abstract

Salicin, the key constituent of white willow bark (Salix alba), inhibited angiogenesis and tumour growth in vitro and in vivo by blocking reactive-oxygen-species and ERK pathways, revealing an antitumour/antiangiogenic activity of the willow constituent.

Referenced for these plants

How to cite

Kong, C.S., Kim, K.H., Choi, J.S., Kim, J.E. and others (2014) 'Salicin, an extract from white willow bark, inhibits angiogenesis by blocking the ROS-ERK pathways', Phytotherapy Research, 28(8), pp. 1246-1251. doi:10.1002/ptr.5126

This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.